Who Supplies Cabozantinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Cabozantinib exports, with 66+ registered manufacturers shipping to buyers across 40+ countries — yet a handful of companies dominate the shipments. ROYAL MEDICAL PRIVATE LIMITED holds the largest share at 10.2% (export value: $13.0K). Close behind, GALAXY SUPER SPECIALITY (7.7%, $9.8K). HEALTHBIOTICS PRIVATE LIMITED (5.4%, $6.9K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Cabozantinib? Top Manufacturers & Their Buyers
Flow of Cabozantinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Cabozantinib Supplier Network — Key Market Intelligence
The Cabozantinib export market from India is led by ROYAL MEDICAL PRIVATE LIMITED, which alone commands a 10.2% share, shipping $13.0K worth of product across 13 shipments. The second-largest exporter, GALAXY SUPER SPECIALITY, contributes $9.8K (7.7%) to the overall market. Combined, the top two suppliers alone account for 17.9% of all Cabozantinib exports, indicating a relatively concentrated supply base.
Across all 66 tracked manufacturers, the total Cabozantinib export value stands at $127.4K from 302 shipments. The market average shipment value is $422. The single largest buyer relationship in terms of trade value is MENG MR, receiving $13.0K worth of product.
The combined buyer network spans 5 named purchasing companies, including MENG MR, ROYAL PHARMACEUTICALS L L C FZ, INVOICE RAISED TO, ARROW GENERAL TRADING FZE, MARWA CARGO SERVICES LLC. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ROYAL MEDICAL PRIVATE LIMITED
ROYAL MEDICAL PRIVATE LIMITED is the first-largest Cabozantinib exporter from India, with a market share of 10.2% and a total export value of $13.0K across 13 shipments. Their average shipment value of $1.0K is above the market average of $422, suggesting premium or bulk contract pricing.
ROYAL MEDICAL PRIVATE LIMITED serves 1 named buyer in our database. MENG MR is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• MENG MR — $13.0K across 13 shipments (100.0% of this supplier's total exports)
Key Insight: ROYAL MEDICAL PRIVATE LIMITED's per-shipment value of $1.0K is 137% above the market average of $422, consistent with large-order contracts or value-added formulations.
2GALAXY SUPER SPECIALITY
GALAXY SUPER SPECIALITY is the second-largest Cabozantinib exporter from India, with a market share of 7.7% and a total export value of $9.8K across 10 shipments. Their average shipment value of $976 is above the market average of $422, suggesting premium or bulk contract pricing.
GALAXY SUPER SPECIALITY serves 2 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ROYAL PHARMACEUTICALS L L C FZ — $4.9K across 5 shipments (50.0% of this supplier's total exports)
• ROYAL PHARMACEUTICALS L L C FZ — $4.9K across 5 shipments (50.0% of this supplier's total exports)
Key Insight: GALAXY SUPER SPECIALITY's per-shipment value of $976 is 131% above the market average of $422, consistent with large-order contracts or value-added formulations.
3HEALTHBIOTICS PRIVATE LIMITED
HEALTHBIOTICS PRIVATE LIMITED is the third-largest Cabozantinib exporter from India, with a market share of 5.4% and a total export value of $6.9K across 4 shipments. Their average shipment value of $1.7K is above the market average of $422, suggesting premium or bulk contract pricing.
HEALTHBIOTICS PRIVATE LIMITED serves 2 named buyers in our database. TO THE ORDER OF INVO is the dominant customer, accounting for 91.8% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF INVO — $6.4K across 4 shipments (91.8% of this supplier's total exports)
• INVOICE RAISED TO — $571 across 0 shipments (8.2% of this supplier's total exports)
Key Insight: HEALTHBIOTICS PRIVATE LIMITED's per-shipment value of $1.7K is 311% above the market average of $422, consistent with large-order contracts or value-added formulations.
4RMPL PHARMA LLP
RMPL PHARMA LLP is the fourth-largest Cabozantinib exporter from India, with a market share of 5.3% and a total export value of $6.7K across 19 shipments. Their average shipment value of $355 is below the market average of $422, reflecting a high-volume, competitive pricing strategy.
RMPL PHARMA LLP serves 1 named buyer in our database. TO THE ORDER OF is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $6.7K across 19 shipments (100.0% of this supplier's total exports)
Key Insight: RMPL PHARMA LLP operates with high shipment frequency (19 shipments) at a per-shipment value of $355, indicating a broad distribution network with many smaller, regular orders.
5RIZLIFE HEALTHCARE
RIZLIFE HEALTHCARE is the fifth-largest Cabozantinib exporter from India, with a market share of 5.1% and a total export value of $6.5K across 13 shipments. Their average shipment value of $502 is above the market average of $422, suggesting premium or bulk contract pricing.
RIZLIFE HEALTHCARE serves 2 named buyers in our database. TO THE ORDER OF INVO is the dominant customer, accounting for 85.8% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF INVO — $5.6K across 11 shipments (85.8% of this supplier's total exports)
• TO THE ORDER OF INVO — $929 across 2 shipments (14.2% of this supplier's total exports)
Key Insight: RIZLIFE HEALTHCARE's per-shipment value of $502 is 19% above the market average of $422, consistent with large-order contracts or value-added formulations.
6ATLAS ENTERPRISES
ATLAS ENTERPRISES is the fifth-largest Cabozantinib exporter from India, with a market share of 5.0% and a total export value of $6.4K across 18 shipments. Their average shipment value of $356 is below the market average of $422, reflecting a high-volume, competitive pricing strategy.
ATLAS ENTERPRISES serves 2 named buyers in our database. ARROW GENERAL TRADING FZE is the dominant customer, accounting for 68.1% of this supplier's tracked business. Top customers include:
• ARROW GENERAL TRADING FZE — $4.4K across 12 shipments (68.1% of this supplier's total exports)
• MARWA CARGO SERVICES LLC — $2.0K across 6 shipments (31.9% of this supplier's total exports)
Key Insight: ATLAS ENTERPRISES operates with high shipment frequency (18 shipments) at a per-shipment value of $356, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Cabozantinib Flows
Once Cabozantinib leaves the manufacturing plants of companies like ROYAL MEDICAL PRIVATE LIMITED and GALAXY SUPER SPECIALITY, it travels to 5 destination markets with a combined import value of $127.4K. Turkey absorbs the largest share at 13.4% ($17.1K), followed by United Arab Emirates (11.4%) and Laos (10.4%).
This geographic spread reflects Cabozantinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Cabozantinib Go? Top Importing Countries & Their Buyers
Trade flow of Cabozantinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Turkey
Turkey ranks as the first-largest destination for Cabozantinib imports from India, with a total trade value of $17.1K across 0 shipments — representing a 13.4% share of all Cabozantinib exports. The average shipment value of $17.1K is above the global average of $422, indicating high-value procurement contracts or branded formulations.
Key Insight: Turkey's per-shipment average of $17.1K (3944% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Turkey is a key market for Cabozantinib imports from India.
2United Arab Emirates
United Arab Emirates ranks as the second-largest destination for Cabozantinib imports from India, with a total trade value of $14.5K across 12 shipments — representing a 11.4% share of all Cabozantinib exports. The average shipment value of $1.2K is above the global average of $422, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Cabozantinib importers in United Arab Emirates: ARROW GENERAL TRADING FZE is the largest buyer, accounting for 30.0% ($4.4K) of this market's total imports.
• ARROW GENERAL TRADING FZE — $4.4K (30.0% of United Arab Emirates's total)
• MARWA CARGO SERVICES LLC — $2.0K (14.1% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $1.2K (187% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Cabozantinib imports from India.
3Laos
Laos ranks as the third-largest destination for Cabozantinib imports from India, with a total trade value of $13.3K across 0 shipments — representing a 10.4% share of all Cabozantinib exports. The average shipment value of $13.3K is above the global average of $422, indicating high-value procurement contracts or branded formulations.
Key Insight: Laos's per-shipment average of $13.3K (3052% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Laos is a key market for Cabozantinib imports from India.
4United States
United States ranks as the fourth-largest destination for Cabozantinib imports from India, with a total trade value of $11.7K across 14 shipments — representing a 9.2% share of all Cabozantinib exports. The average shipment value of $834 is above the global average of $422, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Cabozantinib importers in United States: SAS DE CV is the largest buyer, accounting for 15.6% ($1.8K) of this market's total imports.
• SAS DE CV — $1.8K (15.6% of United States's total)
• COMERCIALIZADORA MEDENOR SA DE CV — $1.8K (15.4% of United States's total)
Key Insight: United States's per-shipment average of $834 (98% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Cabozantinib imports from India.
5Egypt
Egypt ranks as the fifth-largest destination for Cabozantinib imports from India, with a total trade value of $10.0K across 4 shipments — representing a 7.8% share of all Cabozantinib exports. The average shipment value of $2.5K is above the global average of $422, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Cabozantinib importers in Egypt: ROYAL PHARMACEUTICALS L L FZ is the largest buyer, accounting for 48.9% ($4.9K) of this market's total imports.
• ROYAL PHARMACEUTICALS L L FZ — $4.9K (48.9% of Egypt's total)
• ROYAL PHARMACEUTICALS L L C FZ — $4.9K (48.9% of Egypt's total)
Key Insight: Egypt's per-shipment average of $2.5K (492% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Egypt is a key market for Cabozantinib imports from India.
People Also Ask — Cabozantinib Supplier & Trade Network
Who are the top suppliers of Cabozantinib from India?+
Which companies buy Cabozantinib from Indian manufacturers?+
Where does Cabozantinib exported from India go?+
What is the market share of the top Cabozantinib supplier from India?+
What is the average shipment value for Cabozantinib exports from India?+
Is Cabozantinib manufactured in India and exported globally?+
Which country imports the most Cabozantinib from India?+
Who are the buyers of Cabozantinib in United Arab Emirates?+
How concentrated is the Cabozantinib supplier market in India?+
How do I find verified buyers for Cabozantinib in specific countries?+
Cabozantinib Trade Network — Key Takeaways
- 1ROYAL MEDICAL PRIVATE LIMITED is India's dominant Cabozantinib exporter with a 10.2% market share and $13.0K in total exports — making it the single most important sourcing entity in this market.
- 2The top 66 suppliers collectively account for 38.8% of all tracked Cabozantinib exports, with a combined trade value of $127.4K.
- 3Turkey is the largest destination market, absorbing 13.4% of India's Cabozantinib exports ($17.1K). United Arab Emirates (11.4%) and Laos (10.4%) follow.
- 4With 302 total shipments averaging $422 each, the Cabozantinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MENG MR, ROYAL PHARMACEUTICALS L L C FZ, ROYAL PHARMACEUTICALS L L C FZ, INVOICE RAISED TO — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 40 countries
Network value: $127.4K
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cabozantinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cabozantinib.
- 2.Flow Mapping: 66 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 302 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 40 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
302 Verified Shipments
66 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists